Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FEMY | AZN | AMGN | GILD | VRTX |
| Company | Femasys Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6813 | 92.33 | 332.46 | 124.82 | 463.00 |
| High | 0.6813 | 92.89 | 333.50 | 125.27 | 463.55 |
| Low | 0.5395 | 92.33 | 330.07 | 124.20 | 457.45 |
| Latest | 0.6098 | 92.77 | 330.43 | 124.58 | 458.11 |
| Change | -0.1003 | -0.13 | -2.50 | -0.12 | -4.79 |
| % Change | -14.12% | -0.14% | -0.75% | -0.10% | -1.03% |
| Volume | 4,472,565 | 1,441,539 | 799,375 | 1,090,935 | 237,702 |
| 20-Day Average Volume | 1,532,104 | 5,272,697 | 3,008,211 | 6,845,047 | 1,350,437 |
| Previous Close | 0.7101 | 92.90 | 332.93 | 124.70 | 462.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8229 | 91.05 | 328.37 | 122.63 | 451.21 |
| 20-Day Raw Stochastic | 14.99% | 90.84% | 54.29% | 69.70% | 85.83% |
| 20-Day Relative Strength | 39.47 | 60.78 | 54.82 | 54.26 | 59.16 |
| Weighted Alpha | -73.28 | +42.73 | +26.41 | +33.08 | +12.91 |
| Today's Opinion | 40% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -29.43% since 12/19/25 | +1.52% since 12/19/25 | +1.06% since 12/19/25 | +0.26% since 12/19/25 | +0.53% since 12/19/25 |
| Low | 0.5403 on 12/29/25 | 90.63 on 12/22/25 | 326.08 on 12/22/25 | 122.84 on 12/22/25 | 453.03 on 12/22/25 |
| High | 0.8662 on 12/22/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -39.83% since 11/28/25 | +0.03% since 11/28/25 | -4.23% since 11/28/25 | -0.98% since 11/28/25 | +5.77% since 11/28/25 |
| Low | 0.5403 on 12/29/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 0.9900 on 12/01/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +72.64% since 09/29/25 | +25.12% since 09/29/25 | +20.76% since 09/29/25 | +10.65% since 09/29/25 | +16.02% since 09/29/25 |
| Low | 0.3420 on 09/30/25 | 73.96 on 09/30/25 | 274.02 on 09/30/25 | 108.46 on 10/02/25 | 385.86 on 09/30/25 |
| High | 1.1100 on 11/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -37.99% since 06/27/25 | +32.78% since 06/27/25 | +19.38% since 06/27/25 | +12.60% since 06/27/25 | +3.93% since 06/27/25 |
| Low | 0.3067 on 08/26/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 1.1100 on 11/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 41,527 | 288,124,864 | 179,276,480 | 154,712,800 | 117,446,520 |
| Shares Outstanding, K | 58,480 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 1,630,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -18,820,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 730,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -4,190,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -2.59 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.27 | 15.34 | 30.24 |